- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Implementation Barriers
Experts discuss the most significant barriers to continuous glucose monitoring (CGM) implementation encountered in their respective roles and how these barriers vary across different patient populations and care settings.
EP: 1.CGM: Redefining Type 2 Diabetes Management
EP: 2.Key Benefits of CGM Technology
EP: 3.CGM's Impact on Clinical Inertia
EP: 4.CGM vs Traditional Monitoring
EP: 5.Understanding CGM Metrics
EP: 6.Health Care System Integration
EP: 7.CGM Coverage and Access
EP: 8.Implementation Barriers
EP: 9.Overcoming Access Challenges
EP: 10.Adoption Strategies
EP: 11.The Metro Nashville Public Schools Initiative
EP: 12.Health Care Quality Impact
EP: 13.Population Outcomes and Return on Value With CGMs
EP: 14.Long-Term Outcomes Assessment
EP: 15.Closing Perspectives
Video content above is prompted by the following:
What are the most significant barriers to CGM implementation you've encountered in your respective roles?
How do these barriers vary across different patient populations and care settings?
FDA Expands Access to Approved CAR T-Cell Therapies by Eliminating REMS
June 30th 2025The FDA has removed Risk Evaluation and Mitigation Strategies (REMS) for approved chimeric antigen receptor (CAR) T-cell therapies for hematologic malignancies, aiming to ease provider burden and expand patient access.
Read More
